Free Trial
→ Free: The Crypto Summit That Could Change Your Life (From Crypto 101 Media) (Ad)tc pixel Free XLO Stock Alerts

Xilio Therapeutics (XLO) Institutional Ownership

Xilio Therapeutics logo
$0.72 +0.00 (+0.03%)
As of 09:58 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Compare

Institutional Ownership Changes (13F Filings) for Xilio Therapeutics (NASDAQ:XLO)

Current
Institutional Ownership
Percentage
54.29%
Number of
Institutional Buyers
(last 12 months)
10
Total
Institutional Inflows
(last 12 months)
$10.85M
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$10.20K
Get XLO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Xilio Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

XLO Institutional Buying and Selling by Quarter

Xilio Therapeutics Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/15/2025 Bridgeway Capital Management LLC56,081$38K0.0%-21.1%0.108%
5/16/2025 ADAR1 Capital Management LLC40,000$29K0.0%N/A0.077%
4/29/2025 Avantax Planning Partners Inc.150,399$109K0.0%N/A0.290%
2/17/2025 Trustees of Columbia University in the City of New York249,635$238K0.0%N/A0.568%
2/17/2025 Balyasny Asset Management L.P.343,230$328K0.0%+26.0%0.781%
2/17/2025 Aptus Capital Advisors LLC41,000$39K0.0%N/A0.093%
2/14/2025 Gilead Sciences Inc.9,105,451$8.70M0.6%N/A20.713%
2/13/2025 Raymond James Financial Inc.50,086$48K0.0%N/A0.114%
2/13/2025 Renaissance Technologies LLC296,617$283K0.0%+11.4%0.675%
2/12/2025 Geode Capital Management LLC358,422$342K0.0%+6.0%0.815%
2/12/2025 Takeda Pharmaceutical Co. Ltd.1,475,121$1.42M5.3%N/A3.356%
2/6/2025 Raymond James Financial Inc.50,086$48K0.0%N/A0.114%
11/16/2024 Geode Capital Management LLC338,192$266K0.0%+85.0%0.769%
8/12/2024 XTX Topco Ltd33,289$32K0.0%N/A0.076%
8/9/2024 Renaissance Technologies LLC295,000$280K0.0%+18.3%0.799%
5/6/2024 Atlas Venture Life Science Advisors LLC992,912$1.07M0.1%-64.0%2.690%
4/22/2024 PFG Investments LLC30,000$32K0.0%N/A0.087%
2/15/2024 Octagon Capital Advisors LP1,785,000$982K0.2%-23.0%6.481%
11/14/2022Ergoteles LLC12,941$38K0.0%-26.3%0.047%
8/15/2022 Laurion Capital Management LP142,900$417K0.0%N/A0.520%
7/27/2022 Bailard Inc.36,632$107K0.0%N/A0.133%
5/16/2022 Deerfield Management Company L.P. Series C2,078,692$14.70M0.3%-3.5%7.567%
5/12/2022 Monashee Investment Management LLC163,066$1.15M0.3%-23.9%0.594%
2/15/2022 Davidson Kempner Capital Management LP29,000$458K0.0%N/A0.109%
2/14/2022 Deerfield Management Company L.P. Series C2,154,061$33.74M0.7%N/A8.078%
2/14/2022 Ghisallo Capital Management LLC30,000$480K0.0%N/A0.113%
2/14/2022 Soleus Capital Management L.P.477,495$7.64M0.8%N/A1.791%
2/11/2022Granite Point Capital Management L.P.10,000$160K0.0%N/A0.038%
2/9/2022 AJU IB Investment Co. Ltd.667,742$10.68M14.9%N/A2.504%
2/8/2022 Northern Trust Corp63,034$1.01M0.0%N/A0.236%
2/7/2022 Monashee Investment Management LLC214,253$3.43M0.8%N/A0.803%
2/7/2022RiverVest Venture Management LLC1,441,444$23.06M16.5%N/A5.406%
2/2/2022 New York State Common Retirement Fund5,568$89K0.0%N/A0.021%
(Data available from 1/1/2016 forward)

XLO Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of XLO shares?

During the previous two years, 15 institutional investors and hedge funds held shares of Xilio Therapeutics. The most heavily invested institutionals were Gilead Sciences Inc. ($8.70M), Takeda Pharmaceutical Co. Ltd. ($1.42M), Atlas Venture Life Science Advisors LLC ($1.07M), Octagon Capital Advisors LP ($982K), Geode Capital Management LLC ($342K), Balyasny Asset Management L.P. ($328K), and Renaissance Technologies LLC ($283K).Learn more on Xilio Therapeutics' institutional investors.

What percentage of Xilio Therapeutics' stock is owned by institutional investors?

54.29% of Xilio Therapeutics' stock is owned by institutional investors. Learn more on XLO's institutional investor holdings.

Which institutional investors have been buying Xilio Therapeutics' stock?

Of the 12 institutional investors that purchased Xilio Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Gilead Sciences Inc. ($9.11M), Takeda Pharmaceutical Co. Ltd. ($1.48M), Trustees of Columbia University in the City of New York ($249.64K), Geode Capital Management LLC ($175.57K), Avantax Planning Partners Inc. ($150.40K), Raymond James Financial Inc. ($100.17K), and Renaissance Technologies LLC ($75.87K).

How much institutional buying is happening at Xilio Therapeutics?

Institutional investors have bought a total of 11,438,406 shares in the last 24 months. This purchase volume represents approximately $10.85M in transactions.

Which of Xilio Therapeutics' major shareholders have been selling company stock?

The following institutional investors have sold Xilio Therapeutics stock in the last 24 months: Bridgeway Capital Management LLC ($15K).

How much institutional selling is happening at Xilio Therapeutics?

Institutional investors have sold a total of 15,000 shares in the last 24 months. This volume of shares sold represents approximately $10.20K in transactions.


Related Companies

This page (NASDAQ:XLO) was last updated on 9/4/2025 by MarketBeat.com Staff
From Our Partners
What's the Best Way to Lower RMD Taxes?
Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...
SmartAsset | Sponsoredtc pixel
He Called Nvidia at $1.10. Now, He Says THIS Stock Will…
A new set of 7 AI stocks are DOMINATING the market. Here’s why one financial guru says they could be the mo...
The Oxford Club | Sponsoredtc pixel
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...
American Alternative | Sponsoredtc pixel
Washington prepares for war
While the headlines obsess over overseas conflicts, Washington has been quietly preparing for something much b...
Porter & Company | Sponsoredtc pixel
Free: The Crypto Summit That Could Change Your Life
27 industry leaders share urgent market intel (free access)... For a very limited time, you can claim your ...
Crypto 101 Media | Sponsoredtc pixel
This Massive Market is Ripe for Disruption by this Nasdaq
Fanatics Hit $31B. This Nasdaq Company Is Building the Next Wave Fanatics built a merch empire by owning th...
i2i Marketing Group, LLC | Sponsoredtc pixel
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
Crypto Income (almost instantly)
How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...
Awesomely, LLC | Sponsoredtc pixel